AbbVie Inc.
AbbVie Inc. (4AB.DU) Stock Competitors & Peer Comparison
See (4AB.DU) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 4AB.DU | €167.40 | +0.00% | 301B | N/A | N/A | +3.45% |
| NOVC.DE | €91.40 | -2.42% | 406.7B | 22.91 | €3.99 | N/A |
| W8A.DE | €10.07 | +0.04% | 8.8B | -1.62 | -€6.30 | +4.90% |
| RDC.DE | €101.60 | +0.00% | 2.1B | -58.85 | -€1.74 | N/A |
| SAE.DE | €88.30 | +0.00% | 1.6B | -26.60 | -€3.32 | N/A |
| 2LYA.F | €1.88 | -0.74% | 152.2M | -23.47 | -€0.08 | N/A |
| NP5.DE | €7.37 | +0.00% | 151.5M | 8.83 | €0.86 | N/A |
| 5EA.DE | €19.20 | +0.00% | 0 | N/A | N/A | N/A |
Stock Comparison
4AB.DU vs NOVC.DE Comparison August 2025
4AB.DU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4AB.DU stands at 301B. In comparison, NOVC.DE has a market cap of 406.7B. Regarding current trading prices, 4AB.DU is priced at €167.40, while NOVC.DE trades at €91.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4AB.DU currently has a P/E ratio of N/A, whereas NOVC.DE's P/E ratio is 22.91. In terms of profitability, 4AB.DU's ROE is +0.96%, compared to NOVC.DE's ROE of +0.86%. Regarding short-term risk, 4AB.DU is less volatile compared to NOVC.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 4AB.DU.Check NOVC.DE's competition here